Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Return on Sales (2016 - 2025)

Historic Return on Sales for Silo Pharma (SILO) over the last 11 years, with Q3 2025 value amounting to 61.61%.

  • Silo Pharma's Return on Sales fell 100800.0% to 61.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 70.41%, marking a year-over-year decrease of 189000.0%. This contributed to the annual value of 60.93% for FY2024, which is 599600.0% down from last year.
  • According to the latest figures from Q3 2025, Silo Pharma's Return on Sales is 61.61%, which was down 100800.0% from 66.81% recorded in Q2 2025.
  • Over the past 5 years, Silo Pharma's Return on Sales peaked at 184.0% during Q3 2021, and registered a low of 100.57% during Q1 2023.
  • Its 5-year average for Return on Sales is 18.05%, with a median of 44.47% in 2024.
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 8109200bps in 2021, then plummeted by -1842200bps in 2022.
  • Silo Pharma's Return on Sales (Quarter) stood at 157.91% in 2021, then tumbled by -100bps to 0.01% in 2022, then plummeted by -703270bps to 58.34% in 2023, then plummeted by -65bps to 96.01% in 2024, then skyrocketed by 36bps to 61.61% in 2025.
  • Its Return on Sales stands at 61.61% for Q3 2025, versus 66.81% for Q2 2025 and 57.22% for Q1 2025.